Knee osteoarthritis: steroid plus tenoxicam more effective than monotherapy

  • Yilmaz E
  • Clin Rheumatol
  • 26 Jun 2019

  • curated by Sarfaroj Khan
  • UK Clinical Digest
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • In patients with knee osteoarthritis (OA), a combination of intra-articular corticosteroid and tenoxicam was more effective for a long period in reducing pain and improving functional recovery compared with tenoxicam and triamcinolone monotherapy.

Why this matters

  • Previous studies have reported that the combination of non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids shows synergistic effects.

Study design

  • 90 patients with knee OA were randomly assigned to receive intra-articular tenoxicam (n=30), triamcinolone (n=30) and triamcinolone plus tenoxicam (n=30).
  • Pain severity (visual analogue scale [VAS]) and pain, stiffness and physical functioning (Western Ontario and McMaster Universities Arthritis Index [WOMAC]) were evaluated at baseline and 1, 3 and 6 months.
  • Funding: None disclosed.

Key results

  • Triamcinolone plus tenoxicam group vs tenoxicam and triamcinolone group had significant improvement in:
    • VAS at:
      • 1 month (0.33±0.47 vs 2.27±0.98 and 1.37±1.21),
      • 3 months (0.93±0.98 vs 6.73±1.14 and 6.87±1.35), and
      • 6 months (1.97±1.12 vs 7.03±0.80 and 7.27±0.86; P<.001 for all>
    • WOMAC at:
      • 1 month (6.67±0.95 vs 10.83±2.61 and 8.83±2.70),
      • 3 months (7.87±1.96 vs 30.33±5.93 and 30.80±7.70), and
      • 6 months (10.43±3.70 vs 31.37±4.38 and 32.83±4.87; P<.001 for all>
  • After 1 month, VAS and WOMAC scores significantly decreased in all 3 groups compared with baseline (P<.01>
  • Steroid plus tenoxicam group had significant improvement in VAS and WOMAC vs only tenoxicam/triamcinolone group at 3- and 6-month follow-up (P<.01>

Limitations

  • Small sample size.
  • Study did not include a control group, oral NSAIDs group and long-term outcome of the combination and monotherapy.